ZA200307506B - Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives. - Google Patents

Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives.

Info

Publication number
ZA200307506B
ZA200307506B ZA200307506A ZA200307506A ZA200307506B ZA 200307506 B ZA200307506 B ZA 200307506B ZA 200307506 A ZA200307506 A ZA 200307506A ZA 200307506 A ZA200307506 A ZA 200307506A ZA 200307506 B ZA200307506 B ZA 200307506B
Authority
ZA
South Africa
Prior art keywords
homoerythromycin
deoxo
aza
derivatives
substituted
Prior art date
Application number
ZA200307506A
Other languages
English (en)
Inventor
Constantine Sklavounos
Tucker John Lloyd
Lulin Wei
Mahon Kerry Peter Jr
Hammen Philip Dietrich
Negri Joanna Teresa
Lehner Richard Shelton
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200307506B publication Critical patent/ZA200307506B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200307506A 2001-04-27 2003-09-26 Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives. ZA200307506B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28720301P 2001-04-27 2001-04-27

Publications (1)

Publication Number Publication Date
ZA200307506B true ZA200307506B (en) 2005-01-26

Family

ID=23101880

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200203252A ZA200203252B (en) 2001-04-27 2002-04-24 Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
ZA200307506A ZA200307506B (en) 2001-04-27 2003-09-26 Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200203252A ZA200203252B (en) 2001-04-27 2002-04-24 Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.

Country Status (23)

Country Link
US (1) US6825327B2 (xx)
EP (2) EP1383780A1 (xx)
JP (3) JP4104463B2 (xx)
KR (1) KR100474225B1 (xx)
CN (4) CN1297564C (xx)
AR (1) AR035871A1 (xx)
AU (1) AU784362B2 (xx)
BR (2) BR0209241A (xx)
CA (2) CA2445306C (xx)
CZ (1) CZ303716B6 (xx)
DK (1) DK1253153T3 (xx)
ES (1) ES2608848T3 (xx)
HK (2) HK1050370A1 (xx)
HU (1) HU230717B1 (xx)
IL (3) IL158059A0 (xx)
MX (2) MXPA03009786A (xx)
PL (2) PL371766A1 (xx)
PT (1) PT1253153T (xx)
RU (2) RU2263117C2 (xx)
SG (1) SG100789A1 (xx)
WO (1) WO2002088158A1 (xx)
YU (1) YU29502A (xx)
ZA (2) ZA200203252B (xx)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
EP1776109B1 (en) * 2004-08-13 2008-12-31 Schering-Plough Ltd. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
JP4644254B2 (ja) 2004-09-23 2011-03-02 シェーリング−プラウ・リミテッド 新規トリフルオロメタンスルホンアニリドオキシムエーテル誘導体の使用による動物における寄生虫の制御
WO2006055565A2 (en) 2004-11-19 2006-05-26 Schering-Plough Ltd. Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
JP2008526948A (ja) * 2005-01-14 2008-07-24 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗マラリア活性を有する9a−カルバモイルおよびチオカルバモイルアザライド
AR054380A1 (es) * 2005-06-09 2007-06-20 Schering Plough Ltd Control de parasitos en animales con derivados de n- ((feniloxi) fenil) -1,1,1-trifluorometansulfonamida y de n-(fenilsulfanil) fenil) -1,1,1-trifluorometansulfonamida
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
CA2672795A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US8084643B2 (en) * 2006-12-13 2011-12-27 Intervet Inc. Water-soluble prodrugs of florfenicol and its analogs
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
PL2957284T3 (pl) 2007-06-27 2018-08-31 E. I. Du Pont De Nemours And Company Sposób zwalczania szkodników zwierzęcych
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
JP2011529895A (ja) * 2008-07-30 2011-12-15 インターベツト・インターナシヨナル・ベー・ベー フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
WO2010086351A1 (en) * 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 3'-n-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin having antimalarial activity
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
UA107804C2 (xx) 2009-08-05 2015-02-25 Du Pont Суміші мезоіонних пестицидів
EP2461684A2 (en) 2009-08-05 2012-06-13 E. I. du Pont de Nemours and Company Mesoionic pesticides
JP2013501063A (ja) 2009-08-05 2013-01-10 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー メソイオン性殺虫剤
KR102060464B1 (ko) 2010-05-27 2019-12-30 이 아이 듀폰 디 네모아 앤드 캄파니 4-[5-[3-클로로-5-(트라이플루오로메틸)페닐]-4,5-다이하이드로-5-(트라이플루오로메틸)-3-아이속사졸릴]-n-[2-옥소-2-[(2,2,2-트라이플루오로에틸)아미노]에틸]-1-나프탈렌카르복스아미드의 결정 형태
EP2588084B1 (en) * 2010-07-01 2023-11-22 Elanco Tiergesundheit AG Antibiotic compositions comprising tulathromycin
WO2012038372A1 (en) 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
CN102295672B (zh) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 一种泰拉菌素的合成方法
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
WO2013013834A1 (en) * 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
CN103965273B (zh) 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN108473524B (zh) * 2016-01-18 2021-11-02 浙江海正药业股份有限公司 一种泰拉霉素的制备方法及其中间体
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN106434797A (zh) * 2016-08-25 2017-02-22 艾美科健(中国)生物医药有限公司 一种酶法合成泰拉霉素的工艺
CN106939029B (zh) * 2017-04-28 2020-10-13 艾美科健(中国)生物医药有限公司 一种泰拉霉素的制备方法
CN107556351B (zh) * 2017-08-29 2019-10-18 博瑞生物医药(苏州)股份有限公司 一种泰拉菌素的制备方法
CN107400152B (zh) * 2017-08-29 2019-10-15 博瑞生物医药(苏州)股份有限公司 泰拉菌素草酸盐
CN109535210A (zh) * 2018-12-19 2019-03-29 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质e的方法
AU2020259997A1 (en) 2019-04-18 2021-11-25 Azura Ophthalmics Ltd. Compounds and methods for the treatment of ocular disorders
CN111072730B (zh) * 2019-12-16 2021-01-12 浙江国邦药业有限公司 一种泰拉霉素中间体盐的制备方法及应用
CN112225769A (zh) * 2020-09-21 2021-01-15 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质e的方法
CN113493483A (zh) * 2021-07-05 2021-10-12 上海应用技术大学 一种泰拉霉素的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4518590A (en) 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
EP0549040A1 (en) 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
DK1189912T3 (da) * 1999-05-18 2008-06-30 Pfizer Prod Inc Nye krystallinske former af et makrolid antibiotikum

Also Published As

Publication number Publication date
PL371766A1 (en) 2005-06-27
CZ20021417A3 (cs) 2003-05-14
IL149226A (en) 2008-06-05
BR0209241A (pt) 2004-06-15
HUP0201385A2 (hu) 2003-12-29
SG100789A1 (en) 2003-12-26
CN1295240C (zh) 2007-01-17
HU230717B1 (hu) 2017-11-28
HK1050370A1 (en) 2003-06-20
HK1065803A1 (en) 2005-03-04
BR0201437A (pt) 2003-06-10
KR20020083474A (ko) 2002-11-02
YU29502A (sh) 2005-03-15
CA2383409C (en) 2007-01-02
JP2007091754A (ja) 2007-04-12
US20030064939A1 (en) 2003-04-03
BRPI0201437B8 (pt) 2021-05-25
CN100413879C (zh) 2008-08-27
RU2263117C2 (ru) 2005-10-27
ZA200203252B (en) 2003-10-24
PL353633A1 (en) 2002-11-04
CA2445306A1 (en) 2002-11-07
CN1384108A (zh) 2002-12-11
ES2608848T3 (es) 2017-04-17
IL158059A0 (en) 2004-03-28
JP4100955B2 (ja) 2008-06-11
IL182418A0 (en) 2008-01-06
RU2233287C2 (ru) 2004-07-27
PT1253153T (pt) 2016-12-29
WO2002088158A1 (en) 2002-11-07
EP1383780A1 (en) 2004-01-28
EP1253153B1 (en) 2016-11-02
JP2004528353A (ja) 2004-09-16
CN1530370A (zh) 2004-09-22
JP2002326998A (ja) 2002-11-15
CZ303716B6 (cs) 2013-04-03
RU2003131351A (ru) 2005-02-27
EP1253153A1 (en) 2002-10-30
MXPA02004231A (es) 2002-11-13
CA2383409A1 (en) 2002-10-27
AU784362B2 (en) 2006-03-16
CN1715289A (zh) 2006-01-04
CA2445306C (en) 2008-02-12
CN1167708C (zh) 2004-09-22
US6825327B2 (en) 2004-11-30
JP4104463B2 (ja) 2008-06-18
PL213731B1 (pl) 2013-04-30
IL149226A0 (en) 2002-11-10
AR035871A1 (es) 2004-07-21
KR100474225B1 (ko) 2005-03-08
MXPA03009786A (es) 2004-01-29
HU0201385D0 (xx) 2002-06-29
IL182418A (en) 2012-07-31
AU3563002A (en) 2002-10-31
BRPI0201437B1 (pt) 2017-11-28
CN1297564C (zh) 2007-01-31
CN1503804A (zh) 2004-06-09
DK1253153T3 (da) 2017-01-02

Similar Documents

Publication Publication Date Title
HK1050370A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives.
IL161955A0 (en) A process for preparing 5-dihydro-pyrazolo Ä3,4-cÜpyrid-2-one derivatives
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
ZA200004548B (en) Process for preparing a spread.
ZA200109611B (en) Process for making a pipa-polyol.
IL189161A0 (en) A process for the preparing a 2-nitro-2'-carboxy-diphenylsulfide derivative
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
ZA200108623B (en) Process for preparing imidachloprid.
ZA99278B (en) Novel process for preparing a ketimine.
GB2375974B (en) A process for the preparation of 1, 1, 1, 2-tetrafluoroethane
HK1048112A1 (en) Process for the preparation of a 3-vinylcephem compound.
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
IL146573A0 (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
HUP0401989A3 (en) A process for the preparation of the 14 beta-hydroxy-baccatin iii-1,14-carbonate
IL142341A0 (en) Process for preparing 1,5-diaryl-3-substituted pyrazoles
IL146810A0 (en) Process for preparing 10, 11-methanobenzosuberane derivatives
HUP0302821A2 (hu) Eljárás szubsztituált 5-amino-N-fenil-1,2,4-triazol-3-szulfonamid-származékok előállítására
HUP0402020A3 (en) A process for preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
HK1087414A1 (en) Process for preparing 4"-substituted-9-deoxo-9A-aza-9A-homoerythromycin a derivatives
AU2002344500A1 (en) A process for preparing 2,6-dichloropurine
HUP0204401A3 (en) Process for producing 2,6-dichlorophenol derivatives
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
EP1451178A4 (en) PROCESS FOR PREPARING BEAT D RIBOFURANOSE DERIVATIVES
HUP0300259A3 (en) Process for preparing 5'-acetylstavudine